Please upgrade your browser.
Zometa when added to hormone therapy, following surgery, significantly reduced the risk of cancer returning or death by 36%
"This study is the first large-scale trial to demonstrate the significant antitumor benefit of zoledronic acid," said lead investigator Michael Gnant, M.D., of the Medical University of Vienna.
A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
"In the INTORACT study, we hope to learn more about whether combining TORISEL with other agents in the first-line setting may further improve outcomes for patients with this devastating disease."
The Templates can enhance patient safety by helping clinicians standardize patient care, reduce medication errors and anticipate and manage adverse events.
New York Post writer Michael Starr, chronicles the life of a man whose acting career began as a contract player for RKO in 1937, gaining notice for his role as a prosecutor in 1951's A Place in the Sun, and then in a supporting role in the 1954 Alfred Hitchcock film Rear Window. Burr succumbed to metastasized kidney cancer on September 12, 1993.
North Staffordshire Primary Care Trust has refused to pay for the £3,000-a-month treatment.
While the overall risk was 14 percent, the risk for specific cancers was typically higher. Compared to men with healthy gums, men with a history of gum disease had a 36 percent increased risk of lung cancer, and a 49 percent hike in risk of kidney cancer.
A new initiative to raise philanthropic dollars for accelerating ground-breaking research, will launch tomorrow through an unprecedented collaboration uniting the major television networks.
Don Sutton, the franchise's winningest pitcher, will be honored for his work with his new educational program, "Stay In The Game," which empowers people affected by kidney cancer.
New data show RAD001 (everolimus) may provide an important new treatment option for patients with advanced kidney cancer who have failed standard therapies.
Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher.
|Powered by NeonCRM|